Stockscreener 앱 받기
1.07
8.55%
-0.10
시간 외 거래:
1.08
0.01
+0.93%
전일 마감가:
$1.17
열려 있는:
$1.15
하루 거래량:
1.37M
Relative Volume:
0.98
시가총액:
$102.78M
수익:
$34.48M
순이익/손실:
$-102.07M
주가수익비율:
-0.7329
EPS:
-1.46
순현금흐름:
$-104.90M
1주 성능:
-16.41%
1개월 성능:
-21.90%
6개월 성능:
-45.96%
1년 성능:
-86.26%
1일 변동 폭
$1.07
$1.17
1주일 범위
$1.07
$1.28
52주 변동 폭
$1.07
$7.93
Caribou Biosciences Inc Stock (CRBU) Company Profile
명칭
Caribou Biosciences Inc
전화
510-982-6030
주소
2929 7TH STREET, SUITE 105, BERKELEY
CRBU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
1.07 | 102.78M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-11-08 | 개시 | Cantor Fitzgerald | Neutral |
| 2023-10-31 | 개시 | Evercore ISI | Outperform |
| 2023-07-11 | 개시 | Truist | Buy |
| 2022-02-18 | 개시 | RBC Capital Mkts | Outperform |
| 2021-12-01 | 개시 | Oppenheimer | Outperform |
| 2021-11-30 | 개시 | H.C. Wainwright | Buy |
| 2021-11-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-08-17 | 개시 | BofA Securities | Buy |
| 2021-08-17 | 개시 | Citigroup | Neutral |
| 2021-08-17 | 개시 | SVB Leerink | Outperform |
모두보기
Caribou Biosciences Inc 주식(CRBU)의 최신 뉴스
Caribou Biosciences (CRBU) Expected to Announce Quarterly Earnings on Monday - Defense World
Caribou Biosciences, Inc. (NASDAQ:CRBU) Receives $10.33 Consensus PT from Analysts - Defense World
Institutional investors may adopt severe steps after Caribou Biosciences, Inc.'s (NASDAQ:CRBU) latest 13% drop adds to a year losses - Simply Wall St
Caribou Biosciences stock hits 52-week low at $1.22 - Investing.com
Caribou Biosciences stock hits 52-week low at $1.22 By Investing.com - Investing.com UK
Caribou Biosciences, Inc. (NASDAQ:CRBU) is a favorite amongst institutional investors who own 62% - Yahoo Finance
Caribou Biosciences, Inc. Investors: Please contact the - GlobeNewswire
Caribou Biosciences, Inc. (NASDAQ: CRBU) Investor Alert: Deadline in Lawsuit on February 24, 2025 - openPR
2025-02-24 | Caribou Biosciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your RightsCRBU | NDAQ:CRBU | Press Release - Stockhouse Publishing
Levi & Korsinsky Announces the Filing of a Securities Class - GlobeNewswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Caribou Biosciences, Inc. - EIN News
Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your RightsCRBU - PR Newswire
Shareholders that lost money on Caribou Biosciences, Inc.(CRBU) should contact Levi & Korsinsky about pending Class ActionCRBU - ACCESS Newswire
2025-02-23 | INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences | NDAQ:CRBU | Press Release - Stockhouse Publishing
Faruqi & Faruqi Reminds Caribou Biosciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025CRBU - PR Newswire
CRBU DEADLINE NOTICE: ROSEN, NATIONAL TRIAL COUNSEL, - GlobeNewswire
CRBU DEADLINE NOTICE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Caribou Biosciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 24 Deadline in Securities Class Action – CRBU - GlobeNewswire Inc.
Caribou Biosciences chief scientific officer sells $4,811 in stock By Investing.com - Investing.com Canada
Caribou Biosciences chief legal officer sells shares worth $4,811 By Investing.com - Investing.com South Africa
Caribou Biosciences chief business officer sells shares for $4,811 - Investing.com India
2025-02-21 | Class Action Filed Against Caribou Biosciences, Inc. (CRBU)February 24, 2025 Deadline to JoinContact Levi & Korsinsky | NDAQ:CRBU | Press Release - Stockhouse Publishing
Shareholders that lost money on Caribou Biosciences, - GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences - Newsfile
Lost Money on Caribou Biosciences, Inc.(CRBU)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - Stockhouse Publishing
2025-02-20 | Levi & Korsinsky Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025CRBU | NDAQ:CRBU | Press Release - Stockhouse Publishing
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 24, 2025 in Caribou Biosciences, Inc. Lawsuit – CRBU - TradingView
2025-02-20 | Shareholders of Caribou Biosciences, Inc. Should Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your RightsCRBU | NDAQ:CRBU | Press Release - Stockhouse Publishing
Caribou Biosciences, Inc. Class Action: The Gross Law Firm Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025CRBU - Morningstar
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences - GlobeNewswire
CRBU Deadline: CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud Lawsuit - PR Newswire
CRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
CRBU DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors ... - The Bakersfield Californian
Caribou Biosciences Gets Court Nod for IPO Investor Deal (2) - Bloomberg Law
Levi & Korsinsky Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineCRBU - Stockhouse Publishing
Caribou Biosciences Faces Lawsuit Amid Stock Decline and Clinical Trial Concerns - PUNE.NEWS
Class Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for InvestorsContact Levi & Korsinsky - Stockhouse Publishing
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences - Markets Insider
2025-02-18 | Investors who lost money on Caribou Biosciences, Inc.(CRBU) should contact Levi & Korsinsky about pending Class ActionCRBU | NDAQ:CRBU | Press Release - Stockhouse Publishing
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesCRBU - PR Newswire
Caribou Biosciences to Participate in Upcoming Investor Conferences - The Manila Times
Caribou Biosciences, Inc. Sued for Securities Law - GlobeNewswire
Caribou Biosciences Inc (NASDAQ: CRBU) Has Been Trading Down. What Are The Prospects For The Future? - Stocks Register
2025-02-18 | Caribou Biosciences, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationCRBU | NDAQ:CRBU | Press Release - Stockhouse Publishing
CRBU Lawsuit Alert! Class Action Against Caribou Biosciences Inc. - TipRanks
Exclusive: Caribou's CEO Reveals CRISPR Innovation Strategy at Two Elite Investor Events - StockTitan
Next Generation Genome Editing Market Top Companies Study - openPR
2025-02-17 | Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Caribou Biosciences, Inc. (CRBU) Shareholders | NDAQ:CRBU | Press Release - Stockhouse Publishing
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences - StreetInsider.com
2025-02-16 | Investors in Caribou Biosciences, Inc. Should Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your RightsCRBU | NDAQ:CRBU | Press Release - Stockhouse Publishing
CRBU IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Caribou Biosciences, Inc. - The Bakersfield Californian
CRBU IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, - GlobeNewswire
Caribou Biosciences Inc (CRBU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Caribou Biosciences Inc 주식 (CRBU) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Khan Ruhi Ahmad | Chief Business Officer |
Feb 21 '25 |
Sale |
1.35 |
3,564 |
4,811 |
66,936 |
| Kanner Steven | Chief Scientific Officer |
Feb 21 '25 |
Sale |
1.35 |
3,564 |
4,811 |
431,556 |
| Ryali Sriram | Chief Financial Officer |
Jan 29 '25 |
Buy |
1.42 |
17,360 |
24,651 |
17,360 |
6.45%
1.23%
자본화:
|
볼륨(24시간):